文献速递腹部泌尿生殖技术与安全CTMR

肾脏嗜酸细胞性肿瘤:分类更新、影像学表现与管理的综述

Renal Oncocytic Neoplasms: Review of Classification Updates, Imaging, and Management.
PubMed 文献 · Radiographics · 2026-01-01

该综述基于PubMed/Radigraphics来源文献,系统回顾了WHO肾脏嗜酸细胞性肿瘤分类更新,包括低级别嗜酸细胞性肿瘤、嗜酸性空泡状肿瘤及Birt-Hogg-Dubé综合征相关杂交肿瘤。影像学上各类嗜酸细胞性肿瘤表现相似,术前难以鉴别,导致良性肾肿瘤切除率高。综述指出强化程度、异质性和钙化可能有助于区分良恶性,分子影像和MR指纹技术可能具有应用前景。

要点

  • 嗜酸细胞性肿瘤影像表现相似,术前难以鉴别良恶性,导致高比例良性肾肿瘤被切除
  • 强化程度、异质性和钙化可能有助于区分良性与恶性嗜酸细胞性肿瘤
  • 肿块衰减和异质性可能有助于区分低级别与高级别肿瘤

核心结论

  • 肾脏嗜酸细胞性肿瘤在病理和影像上均存在诊断挑战,术前影像难以可靠区分各亚型,导致良性肿瘤切除率高。
  • 强化程度、异质性和钙化可能是区分良恶性嗜酸细胞性肿瘤的影像特征,衰减和异质性可能区分低级别与高级别肿瘤。
  • 活检证实的嗜酸细胞性肿瘤可安全选择主动监测,但适合该方案的患者筛选标准尚不明确。

研究设计与样本

  • 综述性论文,来源为Radigraphics,检索范围与纳入文献数量原文未报告。
  • 系统回顾WHO肾脏肿瘤分类中嗜酸细胞性肿瘤谱系,涵盖低级别嗜酸细胞性肿瘤、嗜酸性空泡状肿瘤及Birt-Hogg-Dubé综合征相关杂交肿瘤。
  • 讨论影像学诊断困境、术前活检、主动监测及新兴影像技术(分子影像、MR指纹)的应用前景。

关键影像表现/征象

  • 嗜酸细胞性肿瘤影像表现相似,影像上无法自信诊断,导致切除率增加。
  • 肿块强化程度、异质性和钙化可能有助于区分良性与恶性嗜酸细胞性肿瘤。
  • 肿块衰减和异质性可能有助于区分低级别与高级别癌症。
  • 低级别嗜酸细胞性肿瘤和嗜酸性空泡状肿瘤在病理上可与其他嗜酸细胞性肿瘤区分,通常呈惰性行为。

临床应用与阅片要点

  • 日常阅片中遇到肾脏嗜酸细胞性肿瘤时,应评估强化程度、异质性和钙化,以辅助良恶性鉴别。
  • 对于活检证实的嗜酸细胞性肿瘤,可考虑主动监测作为安全的管理选项。
  • 术前肾肿块活检可能具有预防过度切除的作用,但利用率仍低,诊断可能不明确。

局限性

  • 术前活检利用率低,诊断可能模棱两可,肿瘤侵袭性的确定并不总是可靠。
  • 主动监测虽为安全选项,但哪些患者适合该方案仍不确定。
  • 尽管有影像框架辅助分类,区分嗜酸细胞性肿瘤与更具侵袭性的透明细胞亚型仍然具有挑战性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Renal oncocytic neoplasms present diagnostic challenges, both at imaging and pathologic evaluation. The World Health Organization classification of renal neoplasms defines a spectrum of oncocytic neoplasms, including emerging entities that help define previously uncharacterized or mischaracterized tumors. Low-grade oncocytic tumors and eosinophilic vacuolated tumors are distinguishable from other oncocytic neoplasms at pathologic evaluation and typically demonstrate indolent behavior. Nomenclature regarding hybrid neoplasms has been clarified in reference to hereditary cases associated with Birt-Hogg-Dubé syndrome. Preoperative diagnostic difficulties at imaging contribute to high rates of resected benign renal tumors, the majority being renal oncocytomas. The imaging appearances of oncocytic neoplasms are similar, and the inability to confidently diagnose them at imaging has led to increased resection rates. Preoperative renal mass biopsy may be preventative, but its utilization remains low, diagnoses can be equivocal, and establishing tumor aggressiveness may not always be reliable. Malignant renal oncocytic tumors, including chromophobe renal cell carcinoma, are generally considered the less aggressive subtypes of renal cell carcinoma. However, distinguishing them from the more aggressive clear cell subtype remains challenging, despite imaging frameworks designed to aid categorization. Active surveillance is a safe management option among biopsy-confirmed renal oncocytic neoplasms, but it remains uncertain which patients are suitable for this approach. Diagnostic imaging may assist in risk-stratifying oncocytic neoplasms, with mass enhancement, heterogeneity, and calcification potentially differentiating benign from malignant oncocytic neoplasms. Mass attenuation and heterogeneity may differentiate low-grade and high-grade cancers. Molecular imaging and other emerging techniques, such as MR fingerprinting, may play a role in the future. ©RSNA, 2026 Supplemental material is available for this article.

来源:Radiographics,查看原文。版权归原作者所有。

引用

  1. Akobeng MA, Bhayana R, Di Loreto M, et al. Renal Oncocytic Neoplasms: Review of Classification Updates, Imaging, and Management. Radiographics. 2026. PMID: 41955128. doi:10.1148/rg.250131

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。